Global spread of COVID-19 and other infectious diseases
First written in FY2022-Q1. 2 of 4 entries say "Materialised", first in FY2022-Q1. Latest entry: FY2024.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2024RestatedAnnual report
「As movement of people has become more active following the end of the COVID-19 pandemic, we recognize that continued attention is necessary to risks including the rapid global spread and emergence of new infectious diseases.」
The continuing risk of global infectious-disease spread and the emergence of new diseases remains recognized, including after the end of the COVID-19 pandemic. - FY2023RestatedAnnual report
「Risks including the rapid global spread of infectious diseases and the emergence of new infectious diseases continue to increase.」
The focus has shifted from the COVID-19 pandemic itself to the continuing risk of global infectious-disease spread and the emergence of new diseases. - FY2022MaterialisedAnnual report
「As international movement of people becomes more active through the increasing integration of the global economy, risks are increasing, including the rapid global spread and emergence of new infectious diseases, as seen with COVID-19, whose spread has not yet ended.」
The risk of infectious diseases becoming manifest was reaffirmed on the assumption that the COVID-19 pandemic had not yet ended. - FY2022-Q1MaterialisedAnnual report
「Risks are increasing, including the rapid global spread of infectious diseases and the emergence of new infectious diseases, as seen with COVID-19, which continues to spread.」
The risk of business interruption and staff shortages is described on the assumption that the COVID-19 pandemic is continuing in practice.